European Pharmaceutical ReviewEuropean regulator approves Amgen's anti-cholesterol drug RepathaReutersJuly 21 Amgen Inc said the European commission approved its keenly anticipated cholesterol fighting drug, Repatha. The approval covers patients with a genetic predisposition to high cholesterol, those on maximum doses of statins and those who cannot ...European Commission Approves Amgen's New Cholesterol-Lowering Medication ...CNNMoneyUPDATED: Amgen beats Regeneron, Sanofi to world's first big PCSK9 drug OKFierceBiotechEC approves Amgen's cholesterol-lowering medication RepathaEuropean Pharmaceutical ReviewNasdaqall 10 news articles »
European regulator approves Amgen's anti
Rating: 4.5
Diposkan Oleh: Unknown
